President and Chief Commercial Officer · Heron Therapeutics, Inc. (HRTX)

John Poyhonen

A named executive officer of Heron Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,841,120

Salary $509,748Stock awards $583,626

FY2020: $2,670,194

3rd of 5 named executive officers at Heron Therapeutics by FY2021 total.

5 named officers on file for Heron Therapeutics, FY2021

John Poyhonen’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • HRTX’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Heron Therapeutics’s whole pay program stands against its peers

  • Heron Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HRTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get John Poyhonen’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

John Poyhonen compensation by year

Heron Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Heron Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021
Salary$216,731$513,935$509,748
Bonus$0$0$0
Stock awards$0$314,400$583,626
Option awards$4,211,063$1,635,349$535,147
Non-equity incentive$90,751$197,960$203,899
Pension and deferred compensation$0$0$0
All other$6,219$8,550$8,700
Total$4,524,764$2,670,194$1,841,120

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Heron Therapeutics, Inc. DEF 14A filed April 25, 2022, accession 0001564590-22-015345, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Heron Therapeutics, Inc. filed document, accession 0001564590-22-015345. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2022.

$4.5M
$2.7M
$1.8M
FY19
FY20
FY21
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option87,129—$10.55
Option118,750—$18.29
Option27,781—$25.02
Option120,417—$15.72

Per the Outstanding Equity Awards at Fiscal Year-End table in Heron Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

11 Form 4 lines since the FY2021 proxy (filed April 25, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2023-04-13Exercise or conversion—1,250—44,096
2023-04-13Exercise or conversion—4,564—48,660
2023-04-13Tax withholding—2,012$2.8846,648
2023-04-13Exercise or conversion derivative—1,250$0.007,500
2023-04-13Exercise or conversion derivative—4,564$0.0027,936
2023-01-18Grant or award derivative—66,385$0.0066,385
2023-01-13Exercise or conversion—4,564—44,858
2023-01-13Tax withholding—2,012$3.1742,846

The 8 most recent of 11 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Heron Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Barry QuartFormer Chief Executive Officer$5,430,828
Kimberly ManhardExecutive Vice President, Drug Development$1,858,578
John Poyhonen · this pagePresident and Chief Commercial Officer$1,841,120
David SzekeresExecutive Vice President, Chief Operating Officer$1,829,431
Lisa PerazaVice President, Chief Accounting Officer$796,755

The full Heron Therapeutics compensation record

free company brief

This page is one person within Heron Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Heron Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

John Poyhonen's compensation dossier · One-time report. No refunds.